Karuna Therapeutics, Inc. KRTX
Set alert
329.83 0.00 0.00%
At close · Mar 15
329.75 Day range 329.97
52-week range unavailable
- Open
- 329.75
- Prev close
- 329.83
- Mkt cap
- 12.60B
- Vol
- 1.28M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 329.75
- High
- 329.97
- Forward P/E
- -36.49
- Beta
- 1.15
- Short ratio
- 3.60
- Inst. own
- 86.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 2, 2024
- 50-d avg
- 317.71
- 200-d avg
- 230.08
- 1y target
- 324.17
Financial health
Altman Z-Score
91.14 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -27.0×
FY 2017 5y median -26.5× FY 2023
P/S 17887×
FY 2017 5y median 103× FY 2023
P/B 9.3×
FY 2017 5y median 7.6× FY 2023
P/FCF -30.1×
FY 2017 5y median -30.1× FY 2023
EV/EBITDA -23.4×
FY 2017 5y median -23.4× FY 2023
EV/Sales 17628×
FY 2017 5y median 97.9× FY 2023
FCF Yield -3.3%
FY 2017 5y median -3.3% FY 2023
Profitability
Gross Margin -160.1%
FY 2017 5y median 0.0% FY 2023
Operating Margin -75654.0%
FY 2017 5y median -389.2% FY 2023
Net Margin -66311.9%
FY 2017 5y median -389.0% FY 2023
ROE -34.6%
FY 2017 5y median -24.5% FY 2023
ROIC -38.9%
FY 2017 5y median -25.6% FY 2023
ROA -32.5%
FY 2017 5y median -23.8% FY 2023
Growth (YoY)
Revenue -93.9%
FY 2017 FY 2023
Operating Income -70.8%
FY 2017 FY 2023
EPS (diluted) -34.2%
FY 2017 FY 2023
Free Cash Flow -69.8%
FY 2017 FY 2023
Financial Health
Current Ratio 19.3×
FY 2017 5y median 34.0× FY 2023
Quick Ratio 18.8×
FY 2017 5y median 34.0× FY 2023
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2023
Net Debt / EBITDA 0.3×
FY 2017 5y median 0.9× FY 2023
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2023
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-12-31